Among the primarily involved proteins, IL-6, IL-17A, PD-L1, IDO, COX-2, HSP-70, TXN-1, and iNOS were analyzed by real-time PCR at baseline and after 12 months of therapy, in the CRS and DR-HC groups. The gene discussed is NOS2; the disease is congenital rubella syndrome.